- “Eli Lilly resubmits Cymbalta as chronic pain drug” (BusinessWeek)
- “J&J lays out plans for 11 new drug approvals” (FierceBiotech)
- “J&J upbeat on drugs business, cites new medicines” (Reuters)
- “Merck and AstraZeneca: rivals join forces in oncology” (Press release issued by Merck & Co, TradingMarkets.com)
- “Novartis, Wellcome Trust To Develop Vaccine For Typhoid Fever” (Pharmaceutical Business Review)
- “Pfizer tries new uses for failed drugs” (St. Louis Post-Dispatch)
- “FDA urged to halt review on prasugrel over safety issues” (PharmaTimes)
SUBSCRIBE